Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Polaris Venture Partners V, L.p.

Affiliations

  • Large Shareholder at Cardlytics Inc. (CDLX), 2019-06-11
  • Large Shareholder at Pulmatrix Inc. (PULM), 2018-04-06
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2017-07-19
  • Large Shareholder at Selecta Biosciences Inc (SELB), 2016-06-29
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-08-07
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2015-06-19
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder at Ocular Therapeutix Inc (OCUL), 2015-02-04
  • Large Shareholder at Trevena Inc (TRVN), 2014-08-18
  • Large Shareholder at Cerulean Pharma Inc. (CERU), 2014-04-16
  • Large Shareholder at Fate Therapeutics Inc (FATE), 2013-10-07
  • Large Shareholder at Bind Therapeutics Inc (BIND), 2013-09-27
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TTOO $15.02 10,367 Large Shareholder 2,030,917 2015-08-05 Filing
TTOO $15.02 104 Large Shareholder 79,844 2015-08-05 Filing
TTOO $15.02 71 Large Shareholder 58,001 2015-08-05 Filing
TTOO $15.02 202 Large Shareholder 37,961 2015-08-05 Filing
TTOO $15.00 385 Large Shareholder 2,041,284 2015-07-24 Filing